Keith B. Hoffman
Geschäftsführer bei Thuris Corp.
Profil
Keith B.
Hoffman is Chief Operating Officer of Thuris Corp.
and a Director of MicroIslet, Inc. He is a Co-Founder of Microislet, SkipRack and OLAS Pharmaceuticals.
He is an Intellectual Property and Business Development Advisor of Cortex Pharmaceuticals, Tensor Biosciences, CytoStent and Microislet.
Prior to joining Thuris, Dr. Hoffman was Head of Drug Selection and Intellectual Property for Ancile Pharmaceuticals.
He received a PhD from the University of California.
Aktive Positionen von Keith B. Hoffman
| Unternehmen | Position | Beginn |
|---|---|---|
Thuris Corp.
 Thuris Corp. Medical SpecialtiesHealth Technology Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA. | Geschäftsführer | - |
Proteas Bioanalytics, Inc.
 Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Keith B. Hoffman
| Unternehmen | Position | Ende |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Ancile Pharmaceuticals, Inc.
 Ancile Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ancile Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. The private company is based in San Diego, CA. | Corporate Officer/Principal | - |
MicroIslet, Inc.
 MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Keith B. Hoffman
| University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Thuris Corp.
Thuris Corp. Medical SpecialtiesHealth Technology Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA. | Health Technology |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Commercial Services |
Ancile Pharmaceuticals, Inc.
Ancile Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ancile Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. The private company is based in San Diego, CA. | Health Technology |
Proteas Bioanalytics, Inc.
Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Technology Services |
